580 related articles for article (PubMed ID: 23864064)
1. Role of combined BI-RADS assessment using mammography and sonography for evaluation of incidental hypermetabolic lesions in the breast on 18F-FDG PET-CT.
Lim S; Lee EH; Park JM; Chang YW; Kim HH; Jeong SH
Acta Radiol; 2013 Dec; 54(10):1117-24. PubMed ID: 23864064
[TBL] [Abstract][Full Text] [Related]
2. Analysis of incidental focal hypermetabolic uptake in the breast as detected by 18F-FDG PET/CT: clinical significance and differential diagnosis.
Chae EY; Cha JH; Kim HH; Shin HJ; Kim HJ; Oh HY; Koh YH; Moon DH
Acta Radiol; 2012 Jun; 53(5):530-5. PubMed ID: 22593124
[TBL] [Abstract][Full Text] [Related]
3. Mammography and ultrasonography evaluation of unexpected focal 18F-FDG uptakes in breast on PET/CT.
Kim MY; Cho N; Chang JM; Yun BL; Bae MS; Kang KW; Moon WK
Acta Radiol; 2012 Apr; 53(3):249-54. PubMed ID: 22262866
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of metabolic tumor volume assessed by 18F-FDG PET/CT added to SUVmax for characterization of thyroid 18F-FDG incidentaloma.
Kim BH; Kim SJ; Kim H; Jeon YK; Kim SS; Kim IJ; Kim YK
Nucl Med Commun; 2013 Sep; 34(9):868-76. PubMed ID: 23797273
[TBL] [Abstract][Full Text] [Related]
5. Correlation Between
Yu P; Lei J; Xu B; Wang R; Shen Z; Tian J
Acad Radiol; 2020 May; 27(5):682-688. PubMed ID: 31311773
[TBL] [Abstract][Full Text] [Related]
6. A preliminary study to propose a diagnostic algorithm for PET/CT-detected incidental breast lesions: application of BI-RADS lexicon for US in combination with SUVmax.
Bakhshayeshkaram M; Salehi Y; Abbasi M; Hashemi Beni R; Seifi S; Hassanzad M; Jamaati HR; Aghahosseini F
Eur Radiol; 2019 Oct; 29(10):5507-5516. PubMed ID: 30887201
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of incidental finding of focal activity in the breast at 18F-FDG PET/CT.
Kang BJ; Lee JH; Yoo IeR; Kim SH; Choi JJ; Jeong SH; Yim HW
AJR Am J Roentgenol; 2011 Aug; 197(2):341-7. PubMed ID: 21785079
[TBL] [Abstract][Full Text] [Related]
8. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT.
Bogsrud TV; Karantanis D; Nathan MA; Mullan BP; Wiseman GA; Collins DA; Kasperbauer JL; Strome SE; Reading CC; Hay ID; Lowe VJ
Nucl Med Commun; 2007 May; 28(5):373-81. PubMed ID: 17414887
[TBL] [Abstract][Full Text] [Related]
9. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
[TBL] [Abstract][Full Text] [Related]
10. Invasive cribriform carcinoma of the breast: mammographic, sonographic, MRI, and 18 F-FDG PET-CT features.
Lee YJ; Choi BB; Suh KS
Acta Radiol; 2015 Jun; 56(6):644-51. PubMed ID: 24938660
[TBL] [Abstract][Full Text] [Related]
11. The role of the breast radiologist in evaluation of breast incidentalomas detected on 18-fludeoxyglucose positron emission tomography/CT.
Dunne RM; O'Mahony D; Wilson G; McDermott R; O'Keeffe SA
Br J Radiol; 2013 Jun; 86(1026):20130034. PubMed ID: 23568361
[TBL] [Abstract][Full Text] [Related]
12. Incidental Breast Lesions Identified by (18)F-FDG PET/CT: Which Clinical Variables Differentiate between Benign and Malignant Breast Lesions?
Shin KM; Kim HJ; Jung SJ; Lim HS; Lee SW; Cho SH; Jang YJ; Lee HJ; Kim GC; Jung JH; Park JY
J Breast Cancer; 2015 Mar; 18(1):73-9. PubMed ID: 25834614
[TBL] [Abstract][Full Text] [Related]
13. Incidental PET/CT findings in the cancer patient: how should they be managed?
Beatty JS; Williams HT; Aldridge BA; Hughes MP; Vasudeva VS; Gucwa AL; David GS; Lind DS; Kruse EJ; McLoughlin JM
Surgery; 2009 Aug; 146(2):274-81. PubMed ID: 19628085
[TBL] [Abstract][Full Text] [Related]
14. MR imaging in probably benign lesions (BI-RADS category 3) of the breast.
Gökalp G; Topal U
Eur J Radiol; 2006 Mar; 57(3):436-44. PubMed ID: 16316732
[TBL] [Abstract][Full Text] [Related]
15. Supraclavicular lymph nodes detected by 18F-FDG PET/CT in cancer patients: assessment with 18F-FDG PET/CT and sonography.
Lee JH; Kim J; Moon HJ; Cho A; Yun M; Lee JD; Kang WJ
AJR Am J Roentgenol; 2012 Jan; 198(1):187-93. PubMed ID: 22194496
[TBL] [Abstract][Full Text] [Related]
16. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
17. The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin.
Zhang M; Jiang X; Zhang M; Xu H; Zhai G; Li B
J Nucl Med; 2009 Apr; 50(4):506-12. PubMed ID: 19289438
[TBL] [Abstract][Full Text] [Related]
18. Incidental colonic focal FDG uptake on PET/CT: can the maximum standardized uptake value (SUVmax) guide us in the timing of colonoscopy?
van Hoeij FB; Keijsers RG; Loffeld BC; Dun G; Stadhouders PH; Weusten BL
Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):66-71. PubMed ID: 25139518
[TBL] [Abstract][Full Text] [Related]
19. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.
Barrio M; Czernin J; Yeh MW; Palma Diaz MF; Gupta P; Allen-Auerbach M; Schiepers C; Herrmann K
Nucl Med Commun; 2016 Dec; 37(12):1290-1296. PubMed ID: 27612034
[TBL] [Abstract][Full Text] [Related]
20. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
